Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 147   

Articles published

GSK 1,550.34 -8.16 (-0.52%)
price chart
Welch & Forbes Cut Glaxosmithkline Plc (GSK) Stake By $381254, Gnc Holdings ...
Welch & Forbes Llc decreased Glaxosmithkline Plc (GSK) stake by 1.51% reported in 2016Q4 SEC filing. Welch & Forbes Llc sold 10,033 shares as Glaxosmithkline Plc (GSK)'s stock declined 0.09%. The Welch & Forbes Llc holds 656,360 shares with ...
GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at JPMorgan Chase ...  Transcript Daily
Highland Capital Management LLC Has $3.341 Million Stake in GlaxoSmithKline ...  The Cerbat Gem
GlaxoSmithKline plc (LSE:GSK) is an attractive dividend stock, but are there ...
Over the past 10 years GlaxoSmithKline plc (LSE:GSK) has returned an average of 4.93% per year from dividend payouts. The stock now yields roughly 4.78% with a market cap of $100.87 Billion.
GlaxoSmithKline plc subtracted -0.31% in its Stock Price in the Previous ...  Free Observer
Most Active Stock: GlaxoSmithKline plc (GSK)  HugoPress
GlaxoSmithKline plc 5.7% Potential Decrease Indicated by Barclays Capital
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'EQUAL WEIGHT' today by analysts at Barclays Capital.
GlaxoSmithKline plc (GSK) Given Hold Rating at Deutsche Bank AG  The Cerbat Gem
GlaxoSmithKline plc (GSK) Shares Sold by PR Herzig & Co. Inc.  Sports Perspectives
GlaxoSmithKline plc 8.5% Potential Decrease Indicated by Exane BNP Paribas
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERPERFORM' this morning by analysts at Exane BNP Paribas.
GlaxoSmithKline plc (GSK) Receives Hold Rating from Shore Capital  The Cerbat Gem
GlaxoSmithKline plc (GSK) Rating Increased to Hold at Zacks Investment Research
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.
Market Fallers: GlaxoSmithKline plc, Glencore PLC, Hargreaves Lansdown PLC ...
Shares in GlaxoSmithKline plc with ticker code: LON:GSK has moved down -1.87% or -30.83 points during the course of today's session so far.
The GlaxoSmithKline plc's (GSK) Equal Weight Rating Reaffirmed at ...  Petro Global News 24
Geron Corporation's (GERN) is at $2.63 per share and GlaxoSmithKline plc's ...
In recent trading day Geron Corporation (GERN) stock showed the move of 2.33% with the closing price of $2.63. Closing price generally refers to the last price at which a stock trades during a regular trading session.
GlaxoSmithKline plc (the 'Company') will today publish on the Company's website,, its 2017 Notice of Annual General Meeting (the '2017 AGM Notice'), together with its ...
$0.59 EPS Expected for GlaxoSmithKline plc (ADR) (GSK), Akebia Therapeutics ...
Analysts expect GlaxoSmithKline plc (ADR) (NYSE:GSK) to report $0.59 EPS on April, 26.They anticipate $0.02 EPS change or 3.51% from last quarter's $0.57 EPS.
Research Report on: GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (NYSE:GSK) added 0.75% to reach $42.73 in the previous trading session. Overall, 4.9 Million shares exchanged hands versus its average trading volume of 3.28 Million shares.
GlaxoSmithKline plc (GSK) Shares Sold by Pegasus Partners Ltd.  The Cerbat Gem
Searle & CO. Acquires Shares of 15218 GlaxoSmithKline plc (GSK)  Sports Perspectives